Simona M. Sacco

Avezzano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 413 publications

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

Journal: Cephalalgia : an international journal of headache

Published: June 26, 2026

Placebo or active comparator in chronic migraine trials: Balancing evidence and practicality.

Placebo or active comparator in chronic migraine trials: Balancing evidence and practicality.

Journal: Cephalalgia : an international journal of headache

Published: June 25, 2026

Hemorrhagic Transformation Mediates Stress Hyperglycemia Effect on Functional Outcome in Minor Ischemic Stroke.

Hemorrhagic Transformation Mediates Stress Hyperglycemia Effect on Functional Outcome in Minor Ischemic Stroke.

Journal: Journal of the American Heart Association

Published: June 23, 2026

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache

Published: June 19, 2026

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Journal: Cephalalgia : an international journal of headache

Published: June 05, 2026

Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience.

Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience.

Journal: Toxins

Published: June 01, 2026

Correction: What's a migraine day? Towards a consensus definition for clinical care and research - a Delphi panel-based study.

Correction: What's a migraine day? Towards a consensus definition for clinical care and research - a Delphi panel-based study.

Journal: The journal of headache and pain

Published: May 28, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Journal: Journal of neurology

Published: May 20, 2026

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Journal: JAMA network open

Published: April 28, 2026

Showing 1-12 of 413

Last Updated: 09/26/2026